2 terminated, 1 completed, 1 not yet recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Completed 1, Not yet recruiting 1 |
Follow basmisanil: new trials by email Literature Review of basmisanil trials Research Report on basmisanil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome Basmisanil, Placebo - Dup15Q Syndrome | Phase 2 | Not yet recruiting | Newleos Therapeutics, Inc. | 30 | 2026-12-01 | 2026-09-29 |
| A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome Basmisanil, Placebo - Dup15q Syndrome | Phase 2 | Terminated | Hoffmann-La Roche | 7 | 2022-12-16 | 2026-08-18 |
| A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke Basmisanil, Placebo - Stroke | Phase 2 | Terminated | Hoffmann-La Roche | 5 | 2017-02-20 | 2019-01-02 |
| A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics Basmisanil, Placebo - Schizophrenia | Phase 2 | Completed | Hoffmann-La Roche | 214 | 2016-11-30 | 2021-02-09 |
Chromosome 15q, trisomy (1) · Infarction, Middle Cerebral Artery (1) · Polyposis Syndrome, Hereditary Mixed, 1 (1) · Schizophrenia (1) · Stroke (1)
Hoffmann-La Roche (3) · Newleos Therapeutics, Inc. (1)
United States (3) · Spain (2) · France (1) · United Kingdom (1)
2015 (1)